VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy.
TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy. J Natl Cancer Inst. 2020 01 01; 112(1):38-45.
View in:
PubMed
subject areas
Algorithms
Bayes Theorem
Clinical Trials, Phase II as Topic
Computer Simulation
Endpoint Determination
Humans
Immunotherapy
Medical Oncology
Prognosis
Research Design
Sample Size
Software
Treatment Outcome
authors with profiles
ROBERT COLEMAN
YING YUAN